Racial and ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia

Hantel, Andrew MD; Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Visualization; Writing - original draft; Writing - review & editing
Brunner, Andrew M MD; Conceptualization; Data curation; Methodology; Project administration; Supervision; Writing - review & editing
Plascak, Jesse J PhD; Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Validation; Writing - review & editing
Uno, Hajime PhD; Methodology; Supervision; Writing - review & editing
Varela, Juan C MD; Data curation; Project administration; Writing - review & editing
Luskin, Marlise R MD; Conceptualization; Investigation; Supervision; Writing - review & editing
Rebbeck, Timothy R PhD; Conceptualization; Data curation; Methodology; Supervision; Writing - review & editing
Stone, Richard M MD; Conceptualization; Investigation; Supervision; Writing - review & editing
Lathan, Christopher S MD; Conceptualization; Data curation; Investigation; Methodology; Supervision; Writing - review & editing
DeAngelo, Daniel J MD, PhD; Conceptualization; Funding acquisition; Investigation; Supervision; Validation; Writing - review & editing
Abel, Gregory A MD; Conceptualization; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Supervision; Validation; Visualization; Writing - original draft; Writing - review & editing

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
Department of Internal Medicine, Division of Cancer Prevention and Control, The Ohio State University, Columbus, OH, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA

Correspondence to: Andrew Hantel, MD, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA (e-mail: [email protected]).

Received August 4, 2023

Received in revised form February 19, 2024

Accepted March 18, 2024

Revised April 18, 2024

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)

Journal of the National Cancer Institute 116(7):p 1178-1184, July 2024. | DOI: 10.1093/jnci/djae067